<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">
<html><body><html><body><section class="summaryOfFindings"><div class="section-header section-collapse-header" id="CD010173-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"><div class="section-header" id="CD010173-sec-0008"></div> <div class="table" id="CD010173-tbl-0001"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings: conventional oral examination/visual inspection for the detection of oral cavity cancer and oral potentially malignant disorders in apparently healthy adults</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Question</b> </p> </th> <th scope="col" align="left" valign="top" colspan="2" rowspan="1" class="headercell"> <p><b>What is the performance of conventional oral examination/visual inspection for the detection of oral cavity cancer and oral potentially malignant disorders in apparently healthy adults?</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Population</b> </p> </th> <td align="left" valign="top" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>OSCC or OPMD symptom‐free individuals screened opportunistically, or through an organised screening programme </p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Index test</b> </p> </th> <td align="left" valign="top" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Oral examination (conventional oral examination by a dentist or visual inspection by trained healthcare workers) </p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Target condition</b> </p> </th> <td align="left" valign="top" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>OSCC or OPMD</p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Reference</b><b>standard</b> </p> </th> <td align="left" valign="top" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Examination and clinical evaluation by a physician with specialist knowledge or training. Long‐term follow‐up was accepted as a suitable reference standard for those participants who screened negative </p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Study type</b> </p> </th> <td align="left" valign="top" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Individuals attending for opportunistic screening, organised screening programme, validation as part of an organised screening programme, or randomised controlled trial, or screening as part of a routine surveillance appointment </p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Quantity of evidence</b> </p> </th> <td align="left" valign="top" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>10 studies including 25,568 participants. The prevalence varied widely across the studies from 1.4% to 50.9% </p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="3" rowspan="1" class="headercell"> <p><b>Findings</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p>Due to differences in region, setting, nature of the index test, and reference standard we elected not to pool the studies </p> <p>For the 7 studies with low prevalence (10% or less) the sensitivity estimates were highly variable, and ranged from 0.50 (95% CI 0.07 to 0.93) to 0.99 (95% CI 0.97 to 1.00), but the specificity estimates were more consistent and ranged from 0.94 (95% CI 0.88 to 0.97) to 0.99 (95% CI 0.98 to 1.00). For the 3 studies with higher prevalence sensitivity estimates ranged from 0.94 (95% CI 0.90 to 0.97) to 0.97 (95% CI 0.96 to 0.98), and specificities ranged from 0.75 (95% CI 0.73 to 0.77) to 0.98 (95% CI 0.98 to 0.99). For many of the studies the sensitivity estimates were imprecise, often reflective of the low disease prevalence in the samples </p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="2" rowspan="1" class="headercell"> <p><b>Limitations</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Test accuracy certainty of the evidence</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Risk of bias</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3 studies were judged to be at low risk of bias overall. 5 studies were judged to be at unclear risk of bias primarily due to insufficient information regarding blinding of the results of the index test. 2 studies were judged to be at high risk of bias arising from the flow and timing domain (high levels of attrition following a positive screen and time from positive screen to receipt of the reference standard) </p> </td> <td align="" valign="" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>⨁⨁◯◯</p> <p>LOW</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Applicability of evidence to question</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>We judged concern regarding the applicability of the studies to the review question to be high for the patient selection domain for 1 study that recruited males only in a hospital setting, 1 study that recruited male smokers, and 1 study that recruited participants that had previously received treatment for head and neck cancer </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Overall certainty of the evidence</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>We judged the overall certainty of the evidence to be low, and downgraded for inconsistency and indirectness </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="3"> <div class="table-footnote"> <p>CI = confidence interval; OPMD = oral potentially malignant disorders; OSCC = oral squamous cell carcinoma. </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD010173-tbl-0002"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 2.</span> <span class="table-title">Summary of findings: mouth self‐examination for the detection of oral cavity cancer and oral potentially malignant disorders in apparently healthy adults</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Question</b> </p> </th> <th scope="col" align="left" valign="top" colspan="2" rowspan="1" class="headercell"> <p><b>What is the performance of mouth self‐examination for the detection of oral cavity cancer and oral potentially malignant disorders in apparently healthy adults?</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Population</b> </p> </th> <td align="left" valign="top" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>OSCC or OPMD symptom‐free individuals screened through an organised screening programme</p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Index</b><b>test</b> </p> </th> <td align="left" valign="top" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Mouth self‐examination</p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Target</b><b>condition</b> </p> </th> <td align="left" valign="top" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>OSCC or OPMD</p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Reference</b><b>standard</b> </p> </th> <td align="left" valign="top" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Examination and clinical evaluation by a physician with specialist knowledge or training or trained health worker </p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Study type</b> </p> </th> <td align="left" valign="top" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Organised screening programmes</p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Quantity of evidence</b> </p> </th> <td align="left" valign="top" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>4 studies including 35,059 participants. The prevalence varied widely across the studies from 0.6% for the largest study to 63.6% for the smallest study </p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="3" rowspan="1" class="headercell"> <p><b>Findings</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p>Due to the small number of eligible studies and heterogeneity in the region, setting, conduct of index test, and reference standard we elected not to pool the studies </p> <p>In 2 studies the sensitivity was much lower than the specificity (sensitivity 0.18 (95% CI 0.13 to 0.24), specificity 1.00 (95% CI 1.00 to 1.00) and sensitivity 0.09 (95% CI 0.04 to 0.15), specificity 0.95 (95% CI 0.88 to 0.99), respectively). Sensitivity and specificity values were similar for 2 other studies (sensitivity 0.43 (95% CI 0.24 to 0.63), specificity 0.44 (95% CI 0.20 to 0.70) and sensitivity 0.33 (95% CI 0.10 to 0.65), specificity 0.54 (95% CI 0.37 to 0.69), respectively) </p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="2" rowspan="1" class="headercell"> <p><b>Limitations</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Test accuracy certainty of the evidence</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Risk of bias</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The overall risk of bias for the studies that evaluated mouth self‐evaluation was judged to be unclear for 3 studies and high for 1 study </p> </td> <td align="" valign="" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>⨁◯◯◯</p> <p>VERY LOW</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Applicability of evidence to question</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>We judged concern regarding the applicability of the studies to the review question to be high for the patient selection domain for 1 study that recruited and evaluated participants with Fanconi anaemia in a hospital setting, and participants that were identified and invited to participate based on their physician assessed risk of oral cancer </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Overall certainty of the evidence</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>We judged the overall certainty of the evidence to be very low, and downgraded for imprecision, inconsistency, and indirectness </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="3"> <div class="table-footnote"> <p>CI = confidence interval; OPMD = oral potentially malignant disorders; OSCC = oral squamous cell carcinoma. </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD010173-tbl-0003"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 3.</span> <span class="table-title">Summary of findings: vital rinsing (toluidine blue) as an adjunct to conventional oral examination compared to conventional oral examination alone for the detection of oral cavity cancer and oral potentially malignant disorders in apparently healthy adults</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Question</b> </p> </th> <th scope="col" align="left" valign="top" colspan="2" rowspan="1" class="headercell"> <p>What is the performance of vital rinsing (toluidine blue) as an adjunct to conventional oral examination compared to conventional oral examination alone <b>for the detection of oral cavity cancer and oral potentially malignant disorders in apparently healthy adults</b>? </p> </th> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Population</b> </p> </th> <td align="left" valign="top" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>OSCC or OPMD symptom‐free individuals with tobacco habits</p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Index</b><b>test</b> </p> </th> <td align="left" valign="top" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Conventional oral examination plus vital rinsing (toluidine blue)</p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Comparator test</b> </p> </th> <td align="left" valign="top" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Conventional oral examination alone</p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Target</b><b>condition</b> </p> </th> <td align="left" valign="top" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Oral cancer as indicated by the National Cancer Registry</p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Reference</b><b>standard</b> </p> </th> <td align="left" valign="top" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Biopsy and histopathologic diagnosis, long‐term follow‐up through the National Cancer Registry </p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Study type</b> </p> </th> <td align="left" valign="top" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Randomised controlled trial of screening strategies</p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Quantity of evidence</b> </p> </th> <td align="left" valign="top" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>1 study including 7975 participants. 4.6% prevalence in conventional oral examination plus vital rinsing trial arm, 4.4% in conventional oral examination alone trial arm<sup>a</sup></p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="3" rowspan="1" class="headercell"> <p><b>Findings</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="3" rowspan="1" bgcolor="#ffffff"> <p>Conventional oral examination plus vital rinsing: sensitivity 0.40 (95% CI 0.05 to 0.85) and specificity 0.91 (95% CI 0.90 to 0.91) with a prevalence of 0.12% </p> <p>Conventional oral examination alone: sensitivity 0.50 (95% CI 0.12 to 0.88) and specificity 0.92 (95% CI 0.91 to 0.93) with a prevalence of 0.15% </p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="2" rowspan="1" class="headercell"> <p><b>Limitations</b> </p> </th> <th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Test accuracy of certainty of the evidence</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Risk of bias</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk of bias for patient selection, index test, and flow and timing domains, unclear risk of bias for reference standard as whether this was interpreted without knowledge of the results of the index tests is unclear </p> </td> <td align="" valign="" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>⨁⨁⨁◯</p> <p>MODERATE</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Applicability of evidence to question</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>We judged the trial to be of high concern regarding applicability for the patient selection domain as individuals who "lacked oral habits" such as smoking or betel quid chewing were ineligible for the trial </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Overall certainty of the evidence</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>We judged the certainty of the evidence as moderate, and downgraded 1 level due to indirectness </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="3"> <div class="table-footnote"> <p>CI = confidence interval; OPMD = oral potentially malignant disorders; OSCC = oral squamous cell carcinoma. </p> <p><sup>a</sup>Comparative effectiveness for health outcomes. Detection rate of OSCC and OPMDs after referral was 4.6% in conventional oral examination plus vital rinsing arm; 4.4% in conventional oral examination alone (rate ratio 1.05 (95% CI 0.74 to 1.41)). Incidence rate of OSCC (x 10<sup>‐5</sup>) of 28 compared to 35.4. Relative incidence rate of 0.79 (95% CI 0.24 to 1.23). </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD010173-tbl-0004"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 4.</span> <span class="table-title">Summary of findings: remote screening for the detection of oral cavity cancer and oral potentially malignant disorders in apparently healthy adults</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Question</b> </p> </th> <th scope="col" align="left" valign="top" colspan="2" rowspan="1" class="headercell"> <p><b>What is the performance of remote screening for the detection of oral cavity cancer and oral potentially malignant disorders in apparently healthy adults?</b> </p> </th> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Population</b> </p> </th> <td align="left" valign="top" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>OSCC or OPMD symptom‐free individuals screened through an organised screening programme</p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Index</b><b>test</b> </p> </th> <td align="left" valign="top" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Remote screening of the oral cavity</p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Target</b><b>condition</b> </p> </th> <td align="left" valign="top" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>OSCC or OPMD</p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Reference</b><b>standard</b> </p> </th> <td align="left" valign="top" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Examination and clinical evaluation by a physician with specialist knowledge or training or trained health worker </p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Study type</b> </p> </th> <td align="left" valign="top" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Organised screening programme, pilot, and feasibility studies</p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="1" rowspan="1" class="headercell"> <p><b>Quantity of evidence</b> </p> </th> <td align="left" valign="top" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>3 studies including 3600 participants. The prevalence varied across the studies from 12.2% to 30.9% </p> </td> </tr>
<tr class="separated">
<th scope="col" align="" valign="" colspan="3" rowspan="1" class="headercell"> <p><b>Findings</b> </p> </th> </tr>
<tr class="separated">
<td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p>Due to the small number of eligible studies and heterogeneity in the region, setting, and case definition for the target condition we elected not to pool the studies </p> <p>Findings for sensitivity and specificity for each of the studies were as follows: sensitivity 0.85 (95% CI 0.81 to 0.88), specificity 0.99 (95% CI 0.99 to 1.00); sensitivity 0.82 (95% CI 0.57 to 0.96), specificity 1.00 (95% CI 0.91 to 1.00); and sensitivity 0.94 (95% CI 0.70 to 1.00), specificity 0.72 (95% CI 0.63 to 0.80) </p> </td> </tr>
<tr class="separated">
<th scope="col" align="left" valign="top" colspan="2" rowspan="1" class="headercell"> <p><b>Limitations</b> </p> </th> <th scope="col" align="" valign="" colspan="1" rowspan="1" class="headercell"> <p><b>Test accuracy certainty of the evidence</b> </p> </th> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Risk of bias</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>The overall risk of bias was judged to be low in the organised screening programme and unclear in the pilot and feasibility studies due to a lack of information regarding the patient selection and index tests </p> </td> <td align="" valign="" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>⨁◯◯◯</p> <p>VERY LOW</p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Applicability of evidence to question</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Concern regarding the overall applicability of the studies to the review question was high for 2 studies arising from the patient selection domain where the samples were primarily composed of older, male smokers </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Overall certainty of the evidence</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>We judged the certainty of the evidence as very low, and downgraded 2 levels due to indirectness (applicability of the study sample) and for inconsistency </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="3"> <div class="table-footnote"> <p>CI = confidence interval; OPMD = oral potentially malignant disorders; OSCC = oral squamous cell carcinoma. </p> </div> </td> </tr></tfoot>
</table>
</div> </section></section></body></html></body></html>
